ORIENT BIO Inc. (002630.KS) KSC
966.00
+0(+0.00%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 68.54B |
| Enterprise Value | 68.54B |
| P/E Ratio | -54.99 |
| PEG Ratio | -0.39 |
| Price/Sales Ratio | 3.85 |
| Price/Book Ratio | 1.69 |
| Enterprise/Revenue | 3.72 |
| Enterprise/EBITDA | -46.77 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.07 |
| Operating Margin | -0.14 |
Management Effectiveness
| Return On Assets | -0.03 |
| Return On Equity | -0.03 |
Income Statement
| Revenue | 29.75B |
| Revenue/Share | 250.92 |
| Gross Profit | 0 |
| EBITDA | -4.13B |
| Net Income | -2.08B |
| Diluted EPS | -17.57 |
Balance Sheet
| Total Cash | 33.67B |
| Total Cash/Share | 283.94 |
| Total Debt | 3.53B |
| Total Debt/Equity | 0.05 |
| Current Ratio | 11.45 |
| Book Value Per Share | 571.18 |
Price History
| 52-Week Change | -13.6 |
| 52-Week High | 1,544 |
| 52-Week Low | 453 |
| Moving Average 50 Days | 549.08 |
| Moving Average 200 Days | 586.39 |
Statistics
| Average Volume | 1.77M |
| Shares Outstanding | 118.58M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 445441:1000000 |
| Last Split Date | February 21, 2020 |
